FGEN Logo

FibroGen, Inc. (FGEN) 

NASDAQ
Market Cap
$104.95M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
260 of 809
Rank in Industry
153 of 445

Largest Insider Buys in Sector

FGEN Stock Price History Chart

FGEN Stock Performance

About FibroGen, Inc.

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Insider Activity of FibroGen, Inc.

Over the last 12 months, insiders at FibroGen, Inc. have bought $121,354 and sold $16,524 worth of FibroGen, Inc. stock.

On average, over the past 5 years, insiders at FibroGen, Inc. have bought $381,993 and sold $5.29M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Wettig Thane (CEO) — $95,470. Adib Deyaa (Chief Medical Officer) — $25,884.

The last purchase of 22,123 shares for transaction amount of $25,884 was made by Adib Deyaa (Chief Medical Officer) on 2024‑06‑12.

List of Insider Buy and Sell Transactions, FibroGen, Inc.

2024-06-12PurchaseAdib DeyaaChief Medical Officer
22,123
0.023%
$1.17$25,884-3.02%
2024-03-07PurchaseWettig ThaneCEO
50,000
0.0545%
$1.91$95,470-32.02%
2023-09-01SaleHenderson Jeffrey Williamdirector
2,000
0.002%
$1.03$2,0600.00%
2023-08-04SaleHenderson Jeffrey Williamdirector
2,000
0.002%
$1.91$3,820-41.88%
2023-07-11SaleHenderson Jeffrey Williamdirector
2,000
0.0021%
$2.69$5,380-58.24%
2023-07-07SaleConterno Enrique AChief Executive Officer
1,880
0.0021%
$2.80$5,264-57.78%
2023-06-23SaleWettig ThaneChief Commercial Officer
791
0.0009%
$16.53$13,075-92.77%
2023-06-14SaleChung ChristineSVP, China Operations
6,250
0.0068%
$16.79$104,925-92.86%
2023-06-13SaleChung ChristineSVP, China Operations
6,250
0.0066%
$17.60$110,000-93.28%
2023-06-09SaleEDWARDS JEFFREY Ldirector
7,889
0.0084%
$17.19$135,622-92.99%
2023-06-09SaleBlaug Suzannedirector
8,520
0.0091%
$17.20$146,571-92.99%
2023-06-09SaleCravatt Benjamindirector
3,944
0.0042%
$17.17$67,717-92.99%
2023-06-09SaleBrennan Aoifedirector
4,733
0.0051%
$17.19$81,367-92.99%
2023-06-08SaleHenderson Jeffrey Williamdirector
7,000
0.0073%
$17.45$122,185-93.28%
2023-06-08SaleHo Maykindirector
8,520
0.0088%
$17.44$148,591-93.28%
2023-06-07SaleConterno Enrique AChief Executive Officer
8,897
0.0093%
$17.04$151,583-92.99%
2023-06-07SaleChung ChristineSVP, China Operations
3,633
0.0038%
$17.04$61,894-92.99%
2023-06-07SaleEisner MarkEVP, Chief Medical Officer
2,042
0.0021%
$17.04$34,792-92.99%
2023-06-07SaleWettig ThaneChief Commercial Officer
1,758
0.0018%
$17.04$29,951-92.99%
2023-06-07SaleSchoeneck James Adirector
7,100
0.0079%
$18.03$127,987-92.99%

Insider Historical Profitability

14.14%
Conterno Enrique AChief Executive Officer
374722
0.381%
$1.0627+14.48%
Wettig ThaneChief Commercial Officer
470178
0.1101%
$1.0627+7.99%
Adib DeyaaChief Medical Officer
82123
0.0826%
$1.0610
Henderson Jeffrey Williamdirector
28866
0.0294%
$1.0604
RIGGS RORY Bdirector
379200
0.3856%
$1.0607
Cotroneo PatSVP, Finance and CFO
276677
0.2813%
$1.06051
Chung ChristineSVP, China Operations
236327
0.2403%
$1.06029
Yu K PeonyChief Medical Officer
192292
0.1955%
$1.06044
Eisner MarkEVP, Chief Medical Officer
162862
0.1656%
$1.0606
Routti Jormadirector
131540
0.1338%
$1.06012
Kouchakji EliasSVP, Clinical Dev, Drug Safety
109199
0.111%
$1.0601
VALONE FRANK H MDChief Medical Officer
104684
0.1065%
$1.0609
Schoeneck James Adirector
73722
0.075%
$1.0608
Graham JuanChief Financial Officer
71083
0.0723%
$1.0606
MADERO MIGUELdirector
55614
0.0566%
$1.0602
Tamura Toshinaridirector
51700
0.0526%
$1.0604
Neff Thomas BChief Executive Officer
44238
0.045%
$1.060201
KEARNS THOMAS F JRdirector
39764
0.0404%
$1.06015
EDWARDS JEFFREY Ldirector
33977
0.0346%
$1.0601
Kurkijarvi Kalevidirector
33100
0.0337%
$1.06041
Rosenkranz Roberto Pedrodirector
32700
0.0333%
$1.06015
Ho Maykindirector
31501
0.032%
$1.0601
Blaug Suzannedirector
29594
0.0301%
$1.0601
Cravatt Benjamindirector
28736
0.0292%
$1.0601
Brennan Aoifedirector
27947
0.0284%
$1.0601
Lema Geralddirector
3500
0.0036%
$1.0610+19.61%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
PRIMECAP Management Co$33.89M14.514.42M-0.35%-$119,309.500.03
Armistice Capital Llc$18.65M7.987.94M-18.72%-$4.3M0.22
BlackRock$16.37M7.016.97M-3.29%-$557,847.69<0.0001
The Vanguard Group$15.13M6.476.44M-8.62%-$1.43M<0.0001
Acadian Asset Management$5.88M2.522.5M+1.42%+$82,086.840.02
Jacobs Levy Equity Management$5.19M2.222.21M-11.32%-$662,460.320.02
State Street$5.08M2.172.16M+19.45%+$827,662.96<0.0001
Geode Capital Management$4.88M2.092.07M+2.79%+$132,519.83<0.0001
Citadel Advisors LLC$4.73M2.022.01M-15.77%-$885,745.59<0.01
683 Capital Management Llc$4.35M1.861.85M+164.19%+$2.7M0.49
Two Sigma Advisers LP$2.83M1.211.2M-33.11%-$1.4M0.01
Point72 Asset Management$2.54M1.091.08MNew+$2.54M0.01
Two Sigma$1.9M0.82810,271-61.44%-$3.03M<0.01
Pennant Capital Management Llc$1.81M0.77768,4000%+$00.29
Northern Trust$1.78M0.76756,491-2.69%-$49,237.20<0.0001
AQR Capital$1.3M0.55551,280-52.69%-$1.44M<0.01
Assenagon Asset Management S.A.$1.01M0.43428,848-80.74%-$4.23M<0.01
Jane Street Capital$972,581.000.42413,864+9.99%+$88,329.50<0.01
Morgan Stanley$853,680.000.37363,268-55.51%-$1.07M<0.0001
Hudson Bay Capital Management LP$846,000.000.36360,000New+$846,000.000.01
BNY Mellon$700,342.000.3298,018-4.5%-$33,033.94<0.0001
Fidelity Investments$693,753.000.3295,214-13.46%-$107,949.62<0.0001
Zurich Cantonal Bank$691,856.000.3294,407+0.82%+$5,649.40<0.01
Charles Schwab$627,847.000.27267,169+27.75%+$136,363.42<0.0001
Bridgeway Capital Management$512,300.000.22218,000New+$512,300.000.01
BBR Partners$508,643.000.22216,444+1,216.25%+$469,999.630.04
Bank of America$509,817.000.22216,943-17.97%-$111,705.11<0.0001
Ameriprise Financial$482,747.000.21205,424-27.74%-$185,363.53<0.0001
Vantage Consulting Group Inc$459,911.000.2195,7070%+$00.29
Simplex Trading Llc$429,000.000.18182,683+643.22%+$371,278.040.01
Lighthouse Investment Partners, LLC$427,916.000.18182,092+18.42%+$66,570.770.03
Renaissance Technologies$391,000.000.17166,500-75.64%-$1.21M<0.01
RhumbLine Advisers$369,501.000.16157,240+1.73%+$6,290.73<0.0001
Walleye Capital$354,725.000.15150,947New+$354,725.00<0.01
Public Employees Retirement System Of Ohio$282,437.000.12120,186-31.94%-$132,556.40<0.01
T. Rowe Price$276,000.000.12117,258+5.25%+$13,779.05<0.0001
Millennium Management LLC$273,188.000.12116,250-80.86%-$1.15M<0.0001
SEI Investments Company$253,565.000.11107,9000%+$0<0.0001
Ci Private Wealth Llc$239,943.000.1102,1030%+$0<0.0001
UBS$237,514.000.1101,070+24.66%+$46,978.75<0.0001
Goldman Sachs$237,747.000.1101,169-55.35%-$294,673.36<0.0001
D. E. Shaw & Co.$234,941.000.199,975-94.67%-$4.17M<0.0001
JPMorgan Chase$231,700.000.198,596+63.97%+$90,392.52<0.0001
Hightower Advisors$222,000.000.194,699-60.13%-$334,799.23<0.0001
Voya Investment Management LLC$218,259.000.0992,876-54.4%-$260,345.23<0.0001
Engineers Gate Manager Lp$200,124.000.0985,159+0.18%+$361.900.01
Nuveen$195,266.000.0883,0920%+$0<0.0001
HSBC$194,366.000.0882,709+1.51%+$2,885.80<0.0001
Group One Trading$191,344.000.0881,423New+$191,344.000.01
AllianceBernstein$155,688.000.0766,2500%+$0<0.0001